Cargando…

Strategies for Renal Protection in Cardiovascular Interventions

Coronary artery disease is highly prevalent in chronic kidney disease (CKD) and is a risk factor for contrast-associated acute kidney injury (CA-AKI), a complication of cardiovascular procedures that require contrast administration (e.g., coronary angiography, percutaneous coronary intervention [PCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Ziad A., Escaned, Javier, Dudek, Dariusz, Radhakrishnan, Jai, Karimi Galougahi, Keyvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257153/
https://www.ncbi.nlm.nih.gov/pubmed/35790493
http://dx.doi.org/10.4070/kcj.2022.0093
_version_ 1784741278394613760
author Ali, Ziad A.
Escaned, Javier
Dudek, Dariusz
Radhakrishnan, Jai
Karimi Galougahi, Keyvan
author_facet Ali, Ziad A.
Escaned, Javier
Dudek, Dariusz
Radhakrishnan, Jai
Karimi Galougahi, Keyvan
author_sort Ali, Ziad A.
collection PubMed
description Coronary artery disease is highly prevalent in chronic kidney disease (CKD) and is a risk factor for contrast-associated acute kidney injury (CA-AKI), a complication of cardiovascular procedures that require contrast administration (e.g., coronary angiography, percutaneous coronary intervention [PCI]). CA-AKI has a major impact on morbidity, mortality, and healthcare resource utilization. The incidence of CA-AKI is particularly high in patients with pre-existing CKD, advanced age and comorbidities that increase the likelihood of CKD. The focus of the present review is to provide a brief overview on the assessment of the risk for and prevention of CA-AKI in patients undergoing angiography and PCI, including recognition of the important patient- and procedure-related factors that may contribute to CA-AKI. Preventive and treatment strategies, the mainstay of which is volume repletion by normal saline, are briefly discussed. The main focus of the review is placed on technical details of contrast minimization techniques, including ultra-low contrast angiography and zero-contrast PCI. Operator competence in such techniques is important to ensure that procedural challenges in patients with CKD, like vessel calcification, multivessel disease and complex anatomical subsets, are effectively addressed by PCI while minimizing the risk of CA-AKI.
format Online
Article
Text
id pubmed-9257153
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-92571532022-07-06 Strategies for Renal Protection in Cardiovascular Interventions Ali, Ziad A. Escaned, Javier Dudek, Dariusz Radhakrishnan, Jai Karimi Galougahi, Keyvan Korean Circ J State of the Art Review Coronary artery disease is highly prevalent in chronic kidney disease (CKD) and is a risk factor for contrast-associated acute kidney injury (CA-AKI), a complication of cardiovascular procedures that require contrast administration (e.g., coronary angiography, percutaneous coronary intervention [PCI]). CA-AKI has a major impact on morbidity, mortality, and healthcare resource utilization. The incidence of CA-AKI is particularly high in patients with pre-existing CKD, advanced age and comorbidities that increase the likelihood of CKD. The focus of the present review is to provide a brief overview on the assessment of the risk for and prevention of CA-AKI in patients undergoing angiography and PCI, including recognition of the important patient- and procedure-related factors that may contribute to CA-AKI. Preventive and treatment strategies, the mainstay of which is volume repletion by normal saline, are briefly discussed. The main focus of the review is placed on technical details of contrast minimization techniques, including ultra-low contrast angiography and zero-contrast PCI. Operator competence in such techniques is important to ensure that procedural challenges in patients with CKD, like vessel calcification, multivessel disease and complex anatomical subsets, are effectively addressed by PCI while minimizing the risk of CA-AKI. The Korean Society of Cardiology 2022-06-07 /pmc/articles/PMC9257153/ /pubmed/35790493 http://dx.doi.org/10.4070/kcj.2022.0093 Text en Copyright © 2022. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle State of the Art Review
Ali, Ziad A.
Escaned, Javier
Dudek, Dariusz
Radhakrishnan, Jai
Karimi Galougahi, Keyvan
Strategies for Renal Protection in Cardiovascular Interventions
title Strategies for Renal Protection in Cardiovascular Interventions
title_full Strategies for Renal Protection in Cardiovascular Interventions
title_fullStr Strategies for Renal Protection in Cardiovascular Interventions
title_full_unstemmed Strategies for Renal Protection in Cardiovascular Interventions
title_short Strategies for Renal Protection in Cardiovascular Interventions
title_sort strategies for renal protection in cardiovascular interventions
topic State of the Art Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257153/
https://www.ncbi.nlm.nih.gov/pubmed/35790493
http://dx.doi.org/10.4070/kcj.2022.0093
work_keys_str_mv AT aliziada strategiesforrenalprotectionincardiovascularinterventions
AT escanedjavier strategiesforrenalprotectionincardiovascularinterventions
AT dudekdariusz strategiesforrenalprotectionincardiovascularinterventions
AT radhakrishnanjai strategiesforrenalprotectionincardiovascularinterventions
AT karimigalougahikeyvan strategiesforrenalprotectionincardiovascularinterventions